⌘K

Login Start Free

Home/Filings/4/0000898432-21-000730

4//SEC Filing

Scott Christopher K. 4

Accession 0000898432-21-000730

CIK 0001325618other

View on SEC.gov Company Profile

Filed

Nov 16, 7:00 PM ET

Accepted

Nov 17, 6:19 PM ET

Size

18.1 KB

Accession

0000898432-21-000730

Insider Transaction Report

Form 4

Period: 2021-11-15

IRADIMED CORPIRMD

Scott Christopher K.

CFO

Transactions

Award
Common Stock
2021-11-15$9.84/sh+2,027$19,946→ 30,622 total
Sale
Common Stock
2021-11-15$40.10/sh−2,027$81,279→ 28,595 total
Sale
Common Stock
2021-11-16$40.00/sh−4,255$170,200→ 28,595 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-11-15−2,027→ 32,973 total
Exercise: $9.84Exp: 2024-12-15→ Common Stock (2,027 underlying)
Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-11-17−2,003→ 26,715 total
Exercise: $9.84Exp: 2024-12-15→ Common Stock (2,003 underlying)
Award
Common Stock
2021-11-16$9.84/sh+4,255$41,869→ 32,850 total
Award
Common Stock
2021-11-17$9.84/sh+2,003$19,710→ 30,598 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-11-16−4,255→ 28,718 total
Exercise: $9.84Exp: 2024-12-15→ Common Stock (4,255 underlying)
Sale
Common Stock
2021-11-17$40.01/sh−2,003$80,141→ 28,595 total

Footnotes (3)

[F1]This transaction was executed in multiple trades at prices ranging from $40.00 to $41.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and priced at which the transaction was effected.
[F2]This transaction was executed in multiple trades at prices ranging from $40.00 to $40.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and priced at which the transaction was effected.
[F3]This option was granted on 12-15-2014 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

Documents

1 file

4
form4.xmlPrimary

Issuer

IRADIMED CORP

CIK 0001325618

Entity typeother

Related Parties

1

filerCIK 0001613803

Filing Metadata

Form type: 4
Filed: Nov 16, 7:00 PM ET
Accepted: Nov 17, 6:19 PM ET
Size: 18.1 KB

View on SEC.gov